Advertisement

Urine pp 229-237 | Cite as

Exhaled Breath: Another Biomarker Source That Is Complementary to Urine

  • Yongtao Liu
  • Youhe GaoEmail author
Chapter

Abstract

Biomarkers are measurable changes associated with disease. Exhaled breath provides many signs of bodily changes and has been proposed to be a good early biomarker source because it lacks homeostatic mechanisms and the information contained in the breath complements to other similar body fluids, such as urine and tears. Earlier biomarker detection can provide earlier diagnosis, which can bring about more choices and more time for treatment. The benefit of studying exhaled breath in animal models is that most interfering factors can be avoided and earlier changes in disease may be found.

Keywords

Exhaled breath Animal model Biomarkers VOCs Device 

References

  1. Albrecht FW, et al. Influence of the respirator on volatile organic compounds: an animal study in rats over 24 hours. J Breath Res. 2015;9:016007.  https://doi.org/10.1088/1752-7155/9/1/016007.CrossRefPubMedGoogle Scholar
  2. Chim CS, Ooi GC, Loong F, Au AW, Lie AK. Side effects and good effects from new chemotherapeutic agents. Case 3. Bortezomib in primary refractory plasmacytoma. J Clin Oncol. 2005;23:2426–8.  https://doi.org/10.1200/JCO.2005.04.079.CrossRefPubMedGoogle Scholar
  3. de Lacy Costello B, et al. A review of the volatiles from the healthy human body. J Breath Res. 2014;8:014001.  https://doi.org/10.1088/1752-7155/8/1/014001.CrossRefPubMedGoogle Scholar
  4. Fenske JD, Paulson SE. Human breath emissions of VOCs. J Air Waste Manag Assoc. 1999;49:594–8.CrossRefGoogle Scholar
  5. Gao Y. Taking a deep breath. MOJ Proteomics Bioinformatics. 2015a;2Google Scholar
  6. Gao Y. Roadmap to the urine biomarker era. MOJ Proteomics Bioinformatics. 2015b;2Google Scholar
  7. Harshman SW, et al. Storage stability of exhaled breath on Tenax TA. J Breath Res. 2016;10:046008.  https://doi.org/10.1088/1752-7155/10/4/046008.CrossRefPubMedGoogle Scholar
  8. Jia Z, et al. Detection of lung cancer: concomitant volatile organic compounds and metabolomic profiling of six cancer cell lines of different histological origins. ACS Omega. 2018;3:5131–40.  https://doi.org/10.1021/acsomega.7b02035.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Kang S, Paul Thomas CL. How long may a breath sample be stored for at −80 degrees C? A study of the stability of volatile organic compounds trapped onto a mixed Tenax: carbograph trap adsorbent bed from exhaled breath. J Breath Res. 2016;10:026011.  https://doi.org/10.1088/1752-7155/10/2/026011.CrossRefPubMedGoogle Scholar
  10. Kharitonov SA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994;343:133–5.CrossRefGoogle Scholar
  11. Nagaria NC, Cogswell J, Choe JK, Kasimis B. Side effects and good effects from new chemotherapeutic agents. Case 1. Gefitinib-induced interstitial fibrosis. J Clin Oncol. 2005;23:2423–4.  https://doi.org/10.1200/JCO.2005.04.055.CrossRefPubMedGoogle Scholar
  12. Onozawa M, et al. Side effects and good effects from new chemotherapeutic agents. Case 2. Thalidomide-induced interstitial pneumonitis. J Clin Oncol. 2005;23:2425–6.  https://doi.org/10.1200/JCO.2005.04.054.CrossRefPubMedGoogle Scholar
  13. Phillips M, et al. Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinb). 2007;87:44–52.  https://doi.org/10.1016/j.tube.2006.03.004.CrossRefGoogle Scholar
  14. Robroeks CM, et al. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res. 2010;68:75–80.  https://doi.org/10.1203/PDR.0b013e3181df4ea0.CrossRefGoogle Scholar
  15. Rumchev K, Spickett J, Bulsara M, Phillips M, Stick S. Association of domestic exposure to volatile organic compounds with asthma in young children. Thorax. 2004;59:746–51.  https://doi.org/10.1136/thx.2003.013680.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Van Berkel JJ, et al. A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir Med. 2010;104:557–63.  https://doi.org/10.1016/j.rmed.2009.10.018.CrossRefPubMedGoogle Scholar
  17. Weisel CP. Benzene exposure: an overview of monitoring methods and their findings. Chem Biol Interact. 2010;184:58–66.  https://doi.org/10.1016/j.cbi.2009.12.030.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Zhao M, Li X, Li M, Gao Y. Effects of anesthetics pentobarbital sodium and chloral hydrate on urine proteome. Peer J. 2015;3:e813.  https://doi.org/10.7717/peerj.813.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Beijing Key Laboratory of Genetic Engineering Drugs and Biotechnology, Department of Biochemistry and Molecular BiologyBeijing Normal UniversityBeijingPeople’s Republic of China
  2. 2.College of Life SciencesBeijing Normal UniversityBeijingChina

Personalised recommendations